GPCR
Structure Therapeutics Inc.
Latest News for GPCR
In a report released today, Roger Song from Jefferies maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR, with a price target of......
Biotech Structure Therapeutics’ ($GPCR) shares rallied 102.49% on Monday after mid-stage data for its obesity pill topped competing offerings from ......
Shares of Texas-based biotech firm iBio ($IBIO) have climbed as high as 50% over the past 24 hours. This follows a 39.17% gain on Monday and an add......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Structure Therapeutics, Inc. Sponsored ADR (GPCR – R......
Clear Street analyst Kaveri Pohlman maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR today and set a price target of $99.00. P......
Structure Therapeutics, Inc. Sponsored ADR ( ($GPCR) ) has shared an announcement. On December 8, 2025, Structure Therapeutics announced positive r......
If you’re looking for investment ideas right now, several top-rated Wall Street analysts (each with five-star ratings) believe that the following s......
In a report released yesterday, Prakhar Agrawal from Cantor Fitzgerald maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR, with ......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GPCR | $67.06 | -0.6% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Structure Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW